11 min listen
ACCEL Lite: ESC Late-Breaker: MTT:Assessing the Effects of ARBs and Beta-Blockers in Marfan Syndrome
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ACCEL Lite: ESC Late-Breaker: MTT:Assessing the Effects of ARBs and Beta-Blockers in Marfan Syndrome
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ratings:
Length:
12 minutes
Released:
Sep 20, 2022
Format:
Podcast episode
Description
Marfan Syndrome is a rare genetic heart disease, but still affects over a million people worldwide. It causes swelling of the main blood vessel of the heart, which can even tear if major surgery is not performed - usually when the patient is in their 20s or 30s. Researchers form Oxford University worked with teams all over the world to combine results from several trials involving almost 1500 patients - the most powerful study of its kind - and found that two widely available medicines, angiotensin receptor blockers and beta-blockers, work both separately and in combination to slow the rate of expansion of the blood vessel, potentially delaying the need for surgery and the risk of tearing by a decade or more if the drugs are taken together long term. In this interview, Alex Pitcher, MD and William E. Boden MD, FACC, FAHA, with Sun Moon Kim MD FSCAI FACC, discuss the ESC Late-Breaker: MTT: Assessing the Effects of ARBs and Beta-Blockers in Marfan Syndrome.
Released:
Sep 20, 2022
Format:
Podcast episode
Titles in the series (100)
ACCEL Lite: Strategies to Maximize Doses and Introduce New Medication: As HF therapy continues to evolve, barriers like medication cost and non-adherence may impede patient care. Pharmacists can overcome these barriers through collaborative practice agreements and patient and provider education. In this interview, Sean... by ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research